Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease

Simple item page
dc.contributor.authorFiest, Kirsten M.
dc.contributor.authorBernstein, Charles N.
dc.contributor.authorWalker, John R.
dc.contributor.authorGraff, Lesley A.
dc.contributor.authorHitchon, Carol A.
dc.contributor.authorPeschken, Christine A.
dc.contributor.authorZarychanski, Ryan
dc.contributor.authorAbou-Setta, Ahmed
dc.contributor.authorPatten, Scott B.
dc.contributor.authorSareen, Jitender
dc.contributor.authorBolton, James
dc.contributor.authorSinger, Alexander
dc.contributor.authorMarrie, Ruth Ann
dc.date.accessioned2019-01-24T21:11:54Z
dc.date.available2019-01-24T21:11:54Z
dc.date.issued2016
dc.descriptionDon Paty Career Development Award from the MS Society of Canada
dc.descriptionBingham Chair in Gastroenterology
dc.descriptionManitoba Research Chair from Research Manitoba
dc.description.abstractBackground Depression and anxiety are common in inflammatory bowel disease (IBD) and can affect disease outcomes, including quality of life and success of disease treatment. Successful management of psychiatric comorbidities may improve outcomes, though the effectiveness of existing treatments in IBD is unknown. Methods We searched multiple online databases from inception until March 25, 2015, without restrictions on language, date, or location of publication. We included controlled clinical trials conducted in persons with IBD and depression or anxiety. Two independent reviewers reviewed all abstracts and full-text articles and extracted information including trial and participant characteristics. We also assessed the risk of bias. Results Of 768 unique abstracts, we included one trial of pharmacological anxiety treatment in IBD (48 participants), which found an improvement in anxiety symptoms (p < 0.001). There was a high risk of bias in this trial. We found no controlled clinical trials on the treatment of depression in persons with IBD and depression and no controlled clinical trials reporting on psychological interventions for anxiety or depression in IBD. Conclusions Only one trial examined an intervention for anxiety in adults with IBD and no trials studied depression in adults with IBD. The level of evidence is low because of the risk of bias and limited evidence.
dc.description.grantingagencyCanadian Institutes of Health Research
dc.identifier.citationFiest, K. M., Bernstein, C. N., Walker, J. R., Graff, L. A., Hitchon, C. A., … Marrie, R. A. (2016). Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease. BMC Research Notes, 9(1). https://doi.org/10.1186/s13104-016-2204-2
dc.identifier.doi10.1186/s13104-016-2204-2
dc.identifier.doihttp://dx.doi.org/10.11575/PRISM/35779
dc.identifier.grantnumberTHC 316479
dc.identifier.urihttp://hdl.handle.net/1880/109520
dc.publisherBMC
dc.publisher.departmentCritical Care Medicine
dc.publisher.facultyCumming School of Medicine
dc.publisher.hasversionPublished version
dc.publisher.policyhttps://www.biomedcentral.com/about/policies/access-to-articles
dc.rights©  The Author(s) 2016
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectDepression
dc.subjectAnxiety
dc.subjectSystematic review
dc.subjectInflammatory bowel disease
dc.titleSystematic review of interventions for depression and anxiety in persons with inflammatory bowel disease
dc.typeReview
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
2016_Systematic_Review.pdf
Size:
883.72 KB
Format:
Adobe Portable Document Format
Download
Collections
Cumming School of Medicine Research & Publications